Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
60
Number of overlapping holdings
15.4%
% of VHT's 417 holdings also in IXJ
53.6%
% of IXJ's 113 holdings also in VHT
Overlap by Weight
Sector Drift (VHT minus IXJ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in VHT |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.0% | 8.8% | 8.8% |
|
UNITEDHEALTH GROUP INC | 7.9% | 6.5% | 6.5% |
|
JOHNSON & JOHNSON | 4.9% | 5.4% | 4.9% |
|
ABBVIE INC | 5.4% | 4.7% | 4.7% |
|
ABBOTT LABORATORIES | 3.8% | 3.1% | 3.1% |
Position Highlights (Non-Overlapping Exposures)
VHT Overweight Relative to IXJ
|
ELI LILLY & CO | 2.2% |
|
UNITEDHEALTH GROUP INC | 1.4% |
|
ABBVIE INC | 0.7% |
|
ABBOTT LABORATORIES | 0.7% |
|
VEEVA SYSTEMS INC-CLASS A | 0.6% |
|
ALNYLAM PHARMACEUTICALS INC | 0.6% |
|
THERMO FISHER SCIENTIFIC INC | 0.6% |
|
INTUITIVE SURGICAL INC | 0.5% |
|
MERCK & CO. INC. | 0.5% |
|
AMGEN INC | 0.5% |
VHT Underweight Relative to IXJ
 |
ROCHE HOLDING LTD | -3.3% |
 |
ASTRAZENECA PLC | -3.1% |
|
NOVARTIS AG | -3.0% |
 |
NOVO NORDISK A/S-B | -3.0% |
 |
SANOFI-AVENTIS | -1.7% |
|
ESSILOR INTERNATIONAL | -1.1% |
|
GSK PLC | -1.1% |
 |
CSL LIMITED | -1.0% |
 |
TAKEDA PHARMACEUTICAL CO LTD | -0.7% |
|
ALCON, INC. | -0.6% |